Paul Sauer, SVP Process Development, Manufacturing at Vaxcyte, Inc. (PCVX), sold 2,500 shares at $26.74 ($66K) on 2021-01-11, disclosed to the SEC on 2021-01-12.
Scheduled sale ($66k) by SVP Process Development, Manufacturing under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.38 | 973 | $25K | 37.7% |
| 2 | $26.74 | 1,527 | $41K | 62.3% |
| Total | $26.21 avg | 2,500 | $66K | 100% |
| Filing → |
| PCVX | SELL | 2022-07-22 | $75K | — | Filing → |
| PCVX | SELL | 2022-05-25 | $79K | — | Filing → |
| PCVX | SELL | 2022-04-26 | $75K | — | Filing → |